Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Iterum Therapeutics Plc (ITRM)

Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Iterum Therapeutics Plc 25 North Wall Quay DUBLIN L2 D01 H104 IRL

www.iterumtx.com Employees: 9 P: 353-1903-8354

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated urinary tract infections and complicated intra abdominal infections. Iterum Therapeutics plc is based in Dublin, Ireland.

Key Statistics

Overview:

Market Capitalization, $K 23,913
Enterprise Value, $K 20,083
Shares Outstanding, K 52,788
Annual Sales, $ 0 K
Annual Net Income, $ -24,770 K
Last Quarter Sales, $ 390 K
Last Quarter Net Income, $ -8,980 K
EBIT, $ -20,040 K
EBITDA, $ -17,470 K
60-Month Beta 2.91
% of Insider Shareholders 2.40%
% of Institutional Shareholders 9.21%
Float, K 51,521
% Float 97.60%
Short Volume Ratio 0.43

Growth:

1-Year Return -80.00%
3-Year Return -57.80%
5-Year Return -96.57%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.15%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 11/14/25
Next Earnings Date 02/06/26
Earnings Per Share ttm -0.62
EPS Growth vs. Prev Qtr -25.00%
EPS Growth vs. Prev Year 33.33%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/18/22

ITRM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -65.54%
Profit Margin % 0.00%
Debt/Equity -2.88
Price/Sales 43.25
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.15
Interest Coverage -8.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar